Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion

Truist Financial's Rating of Arcus Biosciences on 10/21/2026

On October 21, 2026, Truist Financial updated its outlook on Arcus Biosciences (NYSE:RCUS) with the action "Boost Price Target", setting a price target of $41.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Truist Financial Corporation

DateCompanyAction
10/21/2026
ServiceNow, Inc. stock logo
NOW
ServiceNow
Set Price Target
10/21/2026
JFrog Ltd. stock logo
FROG
JFrog
Boost Price Target
10/21/2026
Atlassian Corporation PLC stock logo
TEAM
Atlassian
Boost Price Target
10/21/2026
Dynatrace, Inc. stock logo
DT
Dynatrace
Boost Price Target
10/20/2026
Genuine Parts Company stock logo
GPC
Genuine Parts
Boost Price Target
10/20/2026
Inspired Entertainment, Inc. stock logo
INSE
Inspired Entertainment
Lower Price Target
More Ratings From Truist Financial Corporation